Generics 7

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Cholestyramine manufacturers

7 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

7 products found

cholestyramine

Oral powder 4 g

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Comments
Reference product: Quantalan® - EU, Questran® - UK
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 26 days

cholestyramine

Powder for oral suspension 4 g

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Comments
Reference product: Cholestyramine®, Sandoz (Epic Pharma)
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 26 days

cholestyramine

Oral suspension 4 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #16400
This company is a contract manufacturer of pharmaceutical products with a history dating back to 1998. They specialize in producing a range of dosage forms, including tablets, capsules, liquid orals, and both general and antibiotic injectables. They cater to major multinational corporations and well-established Indian brands. The company holds GMP certifications and boasts a strong track record in contract manufacturing. Their primary therapy areas are likely diverse due to their broad client base.

Manufacturer usually replies in 16 days

Want to see all 7 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Cholestyramine is a bile acid sequestrant that is primarily used to reduce cholesterol levels in the blood caused by partial bile obstruction. Suppliers most commonly market it in the form of 4g powders for oral suspension. The largest manufacturer supplier of trade name cholestyramine medications is Bristol-Meyers Squib. Although other manufacturing companies also market generic formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 100 sachets of 4mg cholestyramine powder for oral suspension fall into an approximate range of 50.00 EUR to 70.00 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.